These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8312985)

  • 61. Peripheral serotonergic receptor sensitivity in depressive illness.
    Wood K; Swade C; Abou-Saleh M; Coppen A
    J Affect Disord; 1984 Aug; 7(1):59-65. PubMed ID: 6236244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The marketing of 5-hydroxytryptamine: depression or anxiety?
    Healy D
    Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625
    [No Abstract]   [Full Text] [Related]  

  • 63. [Serotonin-2 receptor-mediated intraplatelet calcium mobilization in affective disorders: relevance to the pathophysiology of depression].
    Kusumi I
    Hokkaido Igaku Zasshi; 1993 May; 68(3):325-36. PubMed ID: 8319932
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serotonin 5-HT(2A) receptor gene polymorphism, 5-HT(2A) receptor function and personality traits in healthy subjects: a negative study.
    Kusumi I; Suzuki K; Sasaki Y; Kameda K; Sasaki T; Koyama T
    J Affect Disord; 2002 Apr; 68(2-3):235-41. PubMed ID: 12063151
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression.
    Siever LJ; Murphy DL; Slater S; de la Vega E; Lipper S
    Life Sci; 1984 Mar; 34(11):1029-39. PubMed ID: 6700367
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic indications for serotonin-potentiating compounds: a hypothesis.
    van Praag HM; Kahn R; Asnis GM; Lemus CZ; Brown SL
    Biol Psychiatry; 1987 Feb; 22(2):205-12. PubMed ID: 2434148
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacologic modification of serotonergic function: drugs for the study and treatment of psychiatric and other disorders.
    Fuller RW
    J Clin Psychiatry; 1986 Apr; 47 Suppl():4-8. PubMed ID: 3514585
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tryptophan depletion and its implications for psychiatry.
    Bell C; Abrams J; Nutt D
    Br J Psychiatry; 2001 May; 178():399-405. PubMed ID: 11331552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Noradrenergic and serotoninergic depression?
    Yazici O; Aricioğlu F; Gürvit G; Uçok A; Taştaban Y; Canberk O; Ozgüroğlu M; Durat T; Sahin D
    J Affect Disord; 1993 Feb; 27(2):123-9. PubMed ID: 8382710
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.
    Owens MJ; Nemeroff CB
    Clin Chem; 1994 Feb; 40(2):288-95. PubMed ID: 7508830
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
    Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
    J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology.
    Booij L; Tremblay RE; Szyf M; Benkelfat C
    J Psychiatry Neurosci; 2015 Jan; 40(1):5-18. PubMed ID: 25285876
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Platelet serotonin level predicts survival in amyotrophic lateral sclerosis.
    Dupuis L; Spreux-Varoquaux O; Bensimon G; Jullien P; Lacomblez L; Salachas F; Bruneteau G; Pradat PF; Loeffler JP; Meininger V
    PLoS One; 2010 Oct; 5(10):e13346. PubMed ID: 20967129
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Increased thermal and mechanical nociceptive thresholds in rats with depressive-like behaviors.
    Shi M; Qi WJ; Gao G; Wang JY; Luo F
    Brain Res; 2010 Sep; 1353():225-33. PubMed ID: 20637742
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Depression and antidepressants: molecular and cellular aspects.
    Lanni C; Govoni S; Lucchelli A; Boselli C
    Cell Mol Life Sci; 2009 Sep; 66(18):2985-3008. PubMed ID: 19521663
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Violent acts associated with fluvoxamine treatment.
    Okada F; Okajima K
    J Psychiatry Neurosci; 2001 Sep; 26(4):339-40. PubMed ID: 11590975
    [No Abstract]   [Full Text] [Related]  

  • 78. Abnormalities of serotonin metabolism and nonpsychotic psychiatric disorders.
    Csernansky JG; Sheline YI
    Ann Clin Psychiatry; 1993 Dec; 5(4):275-81. PubMed ID: 8312985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients.
    Mann JJ; McBride PA; Brown RP; Linnoila M; Leon AC; DeMeo M; Mieczkowski T; Myers JE; Stanley M
    Arch Gen Psychiatry; 1992 Jun; 49(6):442-6. PubMed ID: 1376106
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster?
    Apter A; van Praag HM; Plutchik R; Sevy S; Korn M; Brown SL
    Psychiatry Res; 1990 May; 32(2):191-9. PubMed ID: 2367604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.